Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing

Efrat Katsman,Shari Orlanski,Filippo Martignano,Ilana Fox-Fisher,Ruth Shemer,Yuval Dor,Aviad Zick,Amir Eden,Iacopo Petrini,Silvestro G Conticello,Benjamin P Berman
DOI: https://doi.org/10.1186/s13059-022-02710-1
2022-07-15
Abstract:The Oxford Nanopore (ONT) platform provides portable and rapid genome sequencing, and its ability to natively profile DNA methylation without complex sample processing is attractive for point-of-care real-time sequencing. We recently demonstrated ONT shallow whole-genome sequencing to detect copy number alterations (CNAs) from the circulating tumor DNA (ctDNA) of cancer patients. Here, we show that cell type and cancer-specific methylation changes can also be detected, as well as cancer-associated fragmentation signatures. This feasibility study suggests that ONT shallow WGS could be a powerful tool for liquid biopsy.
What problem does this paper attempt to address?